Dr. Behfar Ehdaie

And it allows everyone to reflect on what we're doing and create pride, especially if there's really things are moving in the right directions and everyone's doing their work and all those things sort of support one another.

And it allows everyone to reflect on what we're doing and create pride, especially if there's really things are moving in the right directions and everyone's doing their work and all those things sort of support one another.

And it allows everyone to reflect on what we're doing and create pride, especially if there's really things are moving in the right directions and everyone's doing their work and all those things sort of support one another.

It can't be, you know, once every quarter when I have to report my information to the IRB, I'm going to hurriedly get a meeting together, get the information from my research study assistant, quickly send an email to the IRB. That doesn't work. So I tell all new investigators, make sure you have regular meetings.

It can't be, you know, once every quarter when I have to report my information to the IRB, I'm going to hurriedly get a meeting together, get the information from my research study assistant, quickly send an email to the IRB. That doesn't work. So I tell all new investigators, make sure you have regular meetings.

It can't be, you know, once every quarter when I have to report my information to the IRB, I'm going to hurriedly get a meeting together, get the information from my research study assistant, quickly send an email to the IRB. That doesn't work. So I tell all new investigators, make sure you have regular meetings.

And I think bi-monthly is a very good cadence in our world, especially as busy surgeons. The next factor is when you think of a trial, always think the idea of pilot trials. We want to run before we walk. And some of the ideas we have are really good ideas. I mean, I have, obviously, as you know, some of the most brilliant individuals that I'm fortunate to work with as fellows.

And I think bi-monthly is a very good cadence in our world, especially as busy surgeons. The next factor is when you think of a trial, always think the idea of pilot trials. We want to run before we walk. And some of the ideas we have are really good ideas. I mean, I have, obviously, as you know, some of the most brilliant individuals that I'm fortunate to work with as fellows.

And I think bi-monthly is a very good cadence in our world, especially as busy surgeons. The next factor is when you think of a trial, always think the idea of pilot trials. We want to run before we walk. And some of the ideas we have are really good ideas. I mean, I have, obviously, as you know, some of the most brilliant individuals that I'm fortunate to work with as fellows.

And they come in every year. It feels like they're so prepared academically and they're ready to answer some of the most important questions in our field. And they're ready to write that 800 patient trial. And they probably will do a good job writing that protocol. Yeah.

And they come in every year. It feels like they're so prepared academically and they're ready to answer some of the most important questions in our field. And they're ready to write that 800 patient trial. And they probably will do a good job writing that protocol. Yeah.

And they come in every year. It feels like they're so prepared academically and they're ready to answer some of the most important questions in our field. And they're ready to write that 800 patient trial. And they probably will do a good job writing that protocol. Yeah.

But I always tell them, well, there's so many things we don't know, and getting this trial through an IRB at these numbers is probably going to be a long process because there is a lot to take into account. Let's start with just a pilot phase. Let's start with a small group. Let's learn. Let's see how we're doing things. And frankly, pilot study...

But I always tell them, well, there's so many things we don't know, and getting this trial through an IRB at these numbers is probably going to be a long process because there is a lot to take into account. Let's start with just a pilot phase. Let's start with a small group. Let's learn. Let's see how we're doing things. And frankly, pilot study...

But I always tell them, well, there's so many things we don't know, and getting this trial through an IRB at these numbers is probably going to be a long process because there is a lot to take into account. Let's start with just a pilot phase. Let's start with a small group. Let's learn. Let's see how we're doing things. And frankly, pilot study...

is seen very differently from a regulatory perspective than a large randomized phase three trial. I tell everyone, before you jump and before you start running, walk and start with that initial pilot trial.

is seen very differently from a regulatory perspective than a large randomized phase three trial. I tell everyone, before you jump and before you start running, walk and start with that initial pilot trial.

is seen very differently from a regulatory perspective than a large randomized phase three trial. I tell everyone, before you jump and before you start running, walk and start with that initial pilot trial.

A lot of our grants, what we write in clinical trials, we do a 20-patient study, prove that we could randomize patients, make sure patients understand the trial, and we worked out our multi-center group of institutions that we all communicate with one another.

A lot of our grants, what we write in clinical trials, we do a 20-patient study, prove that we could randomize patients, make sure patients understand the trial, and we worked out our multi-center group of institutions that we all communicate with one another.